Prophylactic potential of pentosan polysulphate in transmissible spongiform encephalopathies - PubMed (original) (raw)

Prophylactic potential of pentosan polysulphate in transmissible spongiform encephalopathies

C Farquhar et al. Lancet. 1999.

No abstract available

PubMed Disclaimer

Comment in

• Pentosan in transmissible spongiform encephalopathies.
  Deli MA, Niwa M, Katamine S, Abrahám CS. Deli MA, et al. Lancet. 1999 Apr 10;353(9160):1272. doi: 10.1016/S0140-6736(05)66946-2. Lancet. 1999. PMID: 10217107 No abstract available.

Similar articles

• Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt-Jakob disease.
  Todd NV, Morrow J, Doh-ura K, Dealler S, O'Hare S, Farling P, Duddy M, Rainov NG. Todd NV, et al. J Infect. 2005 Jun;50(5):394-6. doi: 10.1016/j.jinf.2004.07.015. J Infect. 2005. PMID: 15907546
• Unsuccessful intraventricular pentosan polysulphate treatment of variant Creutzfeldt-Jakob disease.
  Whittle IR, Knight RS, Will RG. Whittle IR, et al. Acta Neurochir (Wien). 2006 Jun;148(6):677-9; discussion 679. doi: 10.1007/s00701-006-0772-y. Epub 2006 Apr 7. Acta Neurochir (Wien). 2006. PMID: 16598408
• Experimental treatments for human transmissible spongiform encephalopathies: is there a role for pentosan polysulfate?
  Rainov NG, Tsuboi Y, Krolak-Salmon P, Vighetto A, Doh-Ura K. Rainov NG, et al. Expert Opin Biol Ther. 2007 May;7(5):713-26. doi: 10.1517/14712598.7.5.713. Expert Opin Biol Ther. 2007. PMID: 17477808 Review.
• Long term survival in a patient with variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulphate.
  Parry A, Baker I, Stacey R, Wimalaratna S. Parry A, et al. J Neurol Neurosurg Psychiatry. 2007 Jul;78(7):733-4. doi: 10.1136/jnnp.2006.104505. Epub 2007 Feb 21. J Neurol Neurosurg Psychiatry. 2007. PMID: 17314188 Free PMC article.
• [New knowledge about Creutzfeldt-Jakob disease can yield therapeutic possibilities].
  Stølsmark T, Tysnes OB. Stølsmark T, et al. Tidsskr Nor Laegeforen. 2010 Mar 25;130(6):601-4. doi: 10.4045/tidsskr.08.0558. Tidsskr Nor Laegeforen. 2010. PMID: 20349004 Review. Norwegian.

Cited by

• Mechanistic insights into the cure of prion disease by novel antiprion compounds.
  Webb S, Lekishvili T, Loeschner C, Sellarajah S, Prelli F, Wisniewski T, Gilbert IH, Brown DR. Webb S, et al. J Virol. 2007 Oct;81(19):10729-41. doi: 10.1128/JVI.01075-07. Epub 2007 Jul 25. J Virol. 2007. PMID: 17652397 Free PMC article.
• Combining autophagy stimulators and cellulose ethers for therapy against prion disease.
  Abdulrahman BA, Tahir W, Doh-Ura K, Gilch S, Schatzl HM. Abdulrahman BA, et al. Prion. 2019 Jan;13(1):185-196. doi: 10.1080/19336896.2019.1670928. Prion. 2019. PMID: 31578923 Free PMC article.
• Prophylactic effect of dietary seaweed Fucoidan against enteral prion infection.
  Doh-Ura K, Kuge T, Uomoto M, Nishizawa K, Kawasaki Y, Iha M. Doh-Ura K, et al. Antimicrob Agents Chemother. 2007 Jun;51(6):2274-7. doi: 10.1128/AAC.00917-06. Epub 2007 Apr 16. Antimicrob Agents Chemother. 2007. PMID: 17438058 Free PMC article.
• Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study.
  Head MW, Ritchie D, Smith N, McLoughlin V, Nailon W, Samad S, Masson S, Bishop M, McCardle L, Ironside JW. Head MW, et al. Am J Pathol. 2004 Jan;164(1):143-53. doi: 10.1016/S0002-9440(10)63105-7. Am J Pathol. 2004. PMID: 14695328 Free PMC article.
• Small-molecule theranostic probes: a promising future in neurodegenerative diseases.
  Aulić S, Bolognesi ML, Legname G. Aulić S, et al. Int J Cell Biol. 2013;2013:150952. doi: 10.1155/2013/150952. Epub 2013 Nov 12. Int J Cell Biol. 2013. PMID: 24324497 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information